Prosecution Insights
Last updated: November 20, 2026

Yong Soo Chong, USPTO Patent Examiner

Listed by the USPTO as CHONG, YONG SOO

Tech Center 1600 • Art Units: 1617 1623 1627

This examiner grants 44% of resolved cases

Analysis

CHONG, YONG SOO is assigned to Tech Center 1600 and Art Unit 1617. The record covers 894 resolved cases, with an allowance rate of 43.8% and a median of 1426 days to allowance. The interview lift is 41.7%, indicating a meaningful association between interviews and allowance outcomes. The substantial case volume makes these measures useful for planning before substantive responses are prepared.

Top companies include Schedule 1 Therapeutics Inc., Metabolic Technologies, LLC, and The Regents of the University of California. The leading firms are Dentons Davis Brown PC, GOODWIN PROCTER LLP, and POLSINELLI PC (Main Customer Number). These records provide context for biotechnology and academic matters. Counsel may consider purposeful examiner interviews alongside detailed claim analysis and longer-term docket management.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

43.8%
Allow Rate
-16.2% vs TC avg
963
Total Applications
+41.7%
Interview Lift
1426
Avg Prosecution Days
Based on 894 resolved cases, 2023–2026

Rejection Statute Breakdown

1.1%
§101 Eligibility
21.2%
§102 Novelty
52.7%
§103 Obviousness
17.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17760090 ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF Non-Final OA The Regents of the University of California
19065116 DOSE REGIMEN OF VICASINABIN Non-Final OA Hoffmann-La Roche Inc.
18566259 SUBSTITUTED INDOLE COMPOUNDS AND METHODS OF USE THEREOF Final Rejection NOVARTIS PHARMA AG
18740833 SMALL MOLECULE TRAIL GENE INDUCTION BY NORMAL AND TUMOR CELLS AS AN ANTICANCER THERAPY Non-Final OA The Penn State Research Foundation
18553840 DONOR-ACCEPTOR CONJUGATED OLIGOELECTROLYTES FOR CELL LABELLING AND METHODS THEREOF Non-Final OA National University of Singapore
18785196 PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS ASSOCIATED WITH NEURODEGENERATIVE DISEASE OR IMPULSIVE SYMPTOMS ASSOCIATED WITH MENTAL DISEASE CONTAINING BREXPIPRAZOLE OR SALT THEREOF Final Rejection OTSUKA PHARMACEUTICAL CO., LTD.
18866386 ARGINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Non-Final OA Daewoong Pharmaceutical Co., Ltd.
18247561 RILUZOLE FOR THE TREATMENT OF ALZHEIMER'S DISEASE Final Rejection Icahn School of Medicine at Mount Sinai
18272176 METHODS FOR OPTIMIZING CFTR-MODULATOR THERAPY Final Rejection Children's Hospital Medical Center
18835242 METHODS OF PREPARING AND CRYSTALLINE FORMS OF (6A,12A)-17-AMINO-12-METHYL-6,15-BIS(TRIFLUOROMETHYL)-13,19-DIOXA-3,4,18-TRIAZATRICYCLO[12.3.1.12,5]NONADECA-1(18),2,4,14,16-PENTAEN-6-OL Non-Final OA Vertex Pharmaceuticals Incorporated
18260721 USP13 INHIBITORS AND METHODS OF USE THEREOF Non-Final OA GEORGETOWN UNIVERSITY
18254315 COMPOUNDS FOR TREATING SEGMENTAL PROGEROID SYNDROMES Non-Final OA École Nationale Supérieure de Chimie de Montpellier

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Yong Soo Chong's allowance rate?

43.8% of resolved applications examined by Yong Soo Chong were allowed (894 resolved cases), compared with 34.2% across Art Unit 1617 over the last five years.

Does an interview help with examiner Yong Soo Chong?

This examiner's interview lift is +41.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Yong Soo Chong take to allow a patent?

Applications allowed by Yong Soo Chong took 1,426 days on average from filing to allowance.

Which art unit does examiner Yong Soo Chong work in?

Yong Soo Chong examines applications in Art Unit 1617 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month